Транексамова кислота (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Транексамова кислота" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

48nih.gov

4^th place

5^th place

33doi.org

2^nd place

4^th place

12web.archive.org

1^st place

5archive.org

6^th place

4drugs.com

399^th place

754^th place

3compendium.com.ua

low place

238^th place

3lshtm.ac.uk

low place

2who.int

195^th place

71^st place

1medicines.org.uk

3,823^rd place

low place

1ebmedicine.net

low place

7,794^th place

1bbc.co.uk

8^th place

28^th place

1isbtweb.org

low place

4,092^nd place

1fda.gov

447^th place

906^th place

1rcog.org.uk

low place

1anzca.edu.au

low place

1cochrane.org

7,609^th place

9,191^st place

1chemistanddruggist.co.uk

low place

1cmpi.biz

low place

1patient.co.uk

low place

anzca.edu.au

Cyklokapron (tranexamic acid) Product Information (PDF). Архів оригіналу (PDF) за 29 лютого 2016. Процитовано 3 листопада 2015. [Архівовано 2016-02-29 у Wayback Machine.]

archive.org

British national formulary: BNF 69 (вид. 69). British Medical Association. 2015. с. 170. ISBN 9780857111562.
Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE (2013). Tranexamic acid in trauma: how should we use it?. The Journal of Trauma and Acute Care Surgery. 74 (6): 1575—86. doi:10.1097/TA.0b013e318292cc54. PMID 23694890.
Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA (2010). Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstetrics and Gynecology. 116 (4): 865—75. doi:10.1097/AOG.0b013e3181f20177. PMID 20859150.
Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005). Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 102 (4): 727—32. doi:10.1097/00000542-200504000-00006. PMID 15791100.
Flower R, Rang HP, Dale MM, Ritter JM (2007). Rang & Dale's pharmacology. Edinburgh: Churchill Livingstone. ISBN 978-0-443-06911-6.^{[сторінка?]}

bbc.co.uk

news.bbc.co.uk

Drug will save lives of accident victims, says study. BBC News. 2010. Архів оригіналу за 24 червня 2010. Процитовано 3 червня 2016.

chemistanddruggist.co.uk

Chapman, Chris (27 січня 2011). Tranexamic Acid to be available OtC. Community pharmacy news, analysis and CPD. Архів оригіналу за 9 жовтня 2011. [Архівовано 2011-10-09 у Wayback Machine.]

cmpi.biz

dotpharmacy.cmpi.biz

Chapman, Chris (10 лютого 2011). In defence of multiple pharmacies. Community pharmacy news, analysis and CPD. Архів оригіналу за 28 березня 2012. [Архівовано 2012-03-28 у Wayback Machine.]

cochrane.org

Prutsky G, Domecq JP, Salazar CA, Accinelli R (2016). Antifibrinolytic therapy to reduce haemoptysis from any cause. The Cochrane Database of Systematic Reviews. 11: CD008711. doi:10.1002/14651858.CD008711.pub3. PMC 6464927. PMID 27806184.

compendium.com.ua

doi.org

WOMAN Trial Collaborators (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 389 (10084): 2105—2116. doi:10.1016/S0140-6736(17)30638-4. PMC 5446563. PMID 28456509.
Watts G (2016). Utako Okamoto. Lancet. 387 (10035): 2286. doi:10.1016/S0140-6736(16)30697-3. PMID 27308678.
Binz S, McCollester J, Thomas S, Miller J, Pohlman T, Waxman D, Shariff F, Tracy R, Walsh M (2015). CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media. Journal of Blood Transfusion. 2015: 874920. doi:10.1155/2015/874920. PMC 4576020. PMID 26448897.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Melvin JS, Stryker LS, Sierra RJ (2015). Tranexamic Acid in Hip and Knee Arthroplasty. The Journal of the American Academy of Orthopaedic Surgeons. 23 (12): 732—40. doi:10.5435/JAAOS-D-14-00223. PMID 26493971.
Tengborn L, Blombäck M, Berntorp E (2015). Tranexamic acid--an old drug still going strong and making a revival. Thrombosis Research. 135 (2): 231—42. doi:10.1016/j.thromres.2014.11.012. PMID 25559460.
Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE (2013). Tranexamic acid in trauma: how should we use it?. The Journal of Trauma and Acute Care Surgery. 74 (6): 1575—86. doi:10.1097/TA.0b013e318292cc54. PMID 23694890.
Ker K, Roberts I, Shakur H, Coats TJ (2015). Antifibrinolytic drugs for acute traumatic injury (PDF). The Cochrane Database of Systematic Reviews (5): CD004896. doi:10.1002/14651858.CD004896.pub4. PMID 25956410.
CRASH-3 trial collaborators (2019). Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 394 (10210): 1713—1723. doi:10.1016/S0140-6736(19)32233-0. PMC 6853170. PMID 31623894.
Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA (2010). Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstetrics and Gynecology. 116 (4): 865—75. doi:10.1097/AOG.0b013e3181f20177. PMID 20859150.
Naoulou B, Tsai MC (2012). Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstetricia et Gynecologica Scandinavica. 91 (5): 529—37. doi:10.1111/j.1600-0412.2012.01361.x. PMID 22229782.
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K (2011). Henry, David A (ред.). Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd (3): CD001886. doi:10.1002/14651858.cd001886.pub4. PMC 4234031. PMID 21412876.
Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012). Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 344: e3054. doi:10.1136/bmj.e3054. PMC 3356857. PMID 22611164.
Ker K, Prieto-Merino D, Roberts I (2013). Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss (PDF). The British Journal of Surgery. 100 (10): 1271—9. doi:10.1002/bjs.9193. PMID 23839785.
Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005). Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 102 (4): 727—32. doi:10.1097/00000542-200504000-00006. PMID 15791100.
Pernik MN, Dosselman LJ, Aoun SG, Walker AD, Hall K, Peinado Reyes V, McDonagh DL, Bagley CA (2020). The effectiveness of tranexamic acid on operative and perioperative blood loss in long-segment spinal fusions: a consecutive series of 119 primary procedures. Journal of Neurosurgery. Spine. 32 (5): 768—774. doi:10.3171/2019.11.SPINE191174. PMID 31978874.
Forbes CD, Barr RD, Reid G, Thomson C, Prentice CR, McNicol GP, Douglas AS (1972). Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. British Medical Journal. 2 (5809): 311—3. doi:10.1136/bmj.2.5809.311. PMC 1788188. PMID 4553818.
van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE (2019). Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. The Cochrane Database of Systematic Reviews. 4: CD011385. doi:10.1002/14651858.CD011385.pub3. PMC 6474399. PMID 31002742.
Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ (2016). Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. The Cochrane Database of Systematic Reviews. 3: CD009733. doi:10.1002/14651858.CD009733.pub3. PMC 4838155. PMID 26978005.
Siegal DM, Garcia DA, Crowther MA (2014). How I treat target-specific oral anticoagulant-associated bleeding. Blood. 123 (8): 1152—8. doi:10.1182/blood-2013-09-529784. PMID 24385535.
Ker K, Beecher D, Roberts I (2013). Ker, Katharine (ред.). Topical application of tranexamic acid for the reduction of bleeding (PDF). The Cochrane Database of Systematic Reviews (7): CD010562. doi:10.1002/14651858.CD010562.pub2. PMID 23881695.
Logan JK, Pantle H (2016). Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department. American Journal of Health-System Pharmacy. 73 (21): 1755—1759. doi:10.2146/ajhp150829. PMID 27769971.
Williams A, Biffen A, Pilkington N, Arrick L, Williams RJ, Smith ME, Smith M, Birchall J (2017). Haematological factors in the management of adult epistaxis: systematic review. The Journal of Laryngology and Otology. 131 (12): 1093—1107. doi:10.1017/S0022215117002067. PMID 29280698.
Gottlieb M, Koyfman A, Long B (2019). Tranexamic Acid for the Treatment of Epistaxis. Academic Emergency Medicine. 26 (11): 1292—1293. doi:10.1111/acem.13760. PMID 30933392.
Moen CA, Burrell A, Dunning J (2013). Does tranexamic acid stop haemoptysis?. Interactive Cardiovascular and Thoracic Surgery. 17 (6): 991—4. doi:10.1093/icvts/ivt383. PMC 3829500. PMID 23966576.
Prutsky G, Domecq JP, Salazar CA, Accinelli R (2016). Antifibrinolytic therapy to reduce haemoptysis from any cause. The Cochrane Database of Systematic Reviews. 11: CD008711. doi:10.1002/14651858.CD008711.pub3. PMC 6464927. PMID 27806184.
Klepfish A, Berrebi A, Schattner A (2001). Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Archives of Internal Medicine. 161 (5): 767. doi:10.1001/archinte.161.5.767. PMID 11231712.
Zhou LL, Baibergenova A (2017). Melasma: systematic review of the systemic treatments. International Journal of Dermatology. 56 (9): 902—908. doi:10.1111/ijd.13578. PMID 28239840.
Taraz M, Niknam S, Ehsani AH (May 2017). Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatologic Therapy. 30 (3): e12465. doi:10.1111/dth.12465. PMID 28133910.
Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K (2019). Cochrane Eyes and Vision Group (ред.). Medical interventions for traumatic hyphema. The Cochrane Database of Systematic Reviews. 1: CD005431. doi:10.1002/14651858.CD005431.pub4. PMC 6353164. PMID 30640411.
Atsev S, Tomov N (2020). Using antifibrinolytics to tackle neuroinflammation. Neural Regeneration Research. 15 (12): 2203—2206. doi:10.4103/1673-5374.284979. PMC 7749481. PMID 32594031.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Chornenki NL, Um KJ, Mendoza PA, Samienezhad A, Swarup V, Chai-Adisaksopha C, Siegal DM (2019). Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis. Thrombosis Research. 179: 81—86. doi:10.1016/j.thromres.2019.05.003. PMID 31100632.
Law RH, Wu G, Leung EW, Hidaka K, Quek AJ, Caradoc-Davies TT, Jeevarajah D, Conroy PJ, Kirby NM, Norton RS, Tsuda Y, Whisstock JC (2017). X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors. Blood Advances. 1 (12): 766—771. doi:10.1182/bloodadvances.2016004150. PMC 5728053. PMID 29296720.
Wu G, Mazzitelli BA, Quek AJ, Veldman MJ, Conroy PJ, Caradoc-Davies TT, Ooms LM, Tuck KL, Schoenecker JG, Whisstock JC, Law RH (2019). Tranexamic acid is an active site inhibitor of urokinase plasminogen activator. Blood Advances. 3 (5): 729—733. doi:10.1182/bloodadvances.2018025429. PMC 6418500. PMID 30814058.

drugs.com

Tranexamic acid Use During Pregnancy | Drugs.com. www.drugs.com. Архів оригіналу за 21 грудня 2016. Процитовано 14 грудня 2016.
Tranexamic Acid Injection - FDA prescribing information, side effects and uses. www.drugs.com. Архів оригіналу за 21 грудня 2016. Процитовано 14 грудня 2016.
Tranexamic Acid use while Breastfeeding. www.drugs.com. 2014. Архів оригіналу за 18 вересня 2016. Процитовано 27 травня 2016.
Xanodyne Announces FDA Approval of Lysteda (Tranexamic Acid) for Treatment of Women with Heavy Menstrual Bleeding. Drugs.com (англ.). Процитовано 11 грудня 2020.

ebmedicine.net

Cherkas D (2011). Traumatic hemorrhagic shock: advances in fluid management. Emergency Medicine Practice. 13 (11): 1—19, quiz 19–20. PMID 22164397. Архів оригіналу за 18 січня 2012.

fda.gov

accessdata.fda.gov

Lysteda (tranexamic acid) Package Insert (PDF). accessdata.FDA.gov. Архів оригіналу (PDF) за 4 березня 2016. Процитовано 2 листопада 2015.

isbtweb.org

Tranexamic acid. Clinical Transfusion. International Society of Blood Transfusion (ISBT).

lshtm.ac.uk

researchonline.lshtm.ac.uk

Ker K, Roberts I, Shakur H, Coats TJ (2015). Antifibrinolytic drugs for acute traumatic injury (PDF). The Cochrane Database of Systematic Reviews (5): CD004896. doi:10.1002/14651858.CD004896.pub4. PMID 25956410.
Ker K, Prieto-Merino D, Roberts I (2013). Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss (PDF). The British Journal of Surgery. 100 (10): 1271—9. doi:10.1002/bjs.9193. PMID 23839785.
Ker K, Beecher D, Roberts I (2013). Ker, Katharine (ред.). Topical application of tranexamic acid for the reduction of bleeding (PDF). The Cochrane Database of Systematic Reviews (7): CD010562. doi:10.1002/14651858.CD010562.pub2. PMID 23881695.

medicines.org.uk

Cyklokapron Tablets - Summary of Product Characteristics (SPC) - (eMC). www.medicines.org.uk. September 2016. Архів оригіналу за 20 грудня 2016. Процитовано 14 грудня 2016.

nih.gov

pubmed.ncbi.nlm.nih.gov

WOMAN Trial Collaborators (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 389 (10084): 2105—2116. doi:10.1016/S0140-6736(17)30638-4. PMC 5446563. PMID 28456509.
Watts G (2016). Utako Okamoto. Lancet. 387 (10035): 2286. doi:10.1016/S0140-6736(16)30697-3. PMID 27308678.
Binz S, McCollester J, Thomas S, Miller J, Pohlman T, Waxman D, Shariff F, Tracy R, Walsh M (2015). CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media. Journal of Blood Transfusion. 2015: 874920. doi:10.1155/2015/874920. PMC 4576020. PMID 26448897.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Melvin JS, Stryker LS, Sierra RJ (2015). Tranexamic Acid in Hip and Knee Arthroplasty. The Journal of the American Academy of Orthopaedic Surgeons. 23 (12): 732—40. doi:10.5435/JAAOS-D-14-00223. PMID 26493971.
Tengborn L, Blombäck M, Berntorp E (2015). Tranexamic acid--an old drug still going strong and making a revival. Thrombosis Research. 135 (2): 231—42. doi:10.1016/j.thromres.2014.11.012. PMID 25559460.
Cherkas D (2011). Traumatic hemorrhagic shock: advances in fluid management. Emergency Medicine Practice. 13 (11): 1—19, quiz 19–20. PMID 22164397. Архів оригіналу за 18 січня 2012.
Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE (2013). Tranexamic acid in trauma: how should we use it?. The Journal of Trauma and Acute Care Surgery. 74 (6): 1575—86. doi:10.1097/TA.0b013e318292cc54. PMID 23694890.
Ker K, Roberts I, Shakur H, Coats TJ (2015). Antifibrinolytic drugs for acute traumatic injury (PDF). The Cochrane Database of Systematic Reviews (5): CD004896. doi:10.1002/14651858.CD004896.pub4. PMID 25956410.
CRASH-3 trial collaborators (2019). Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 394 (10210): 1713—1723. doi:10.1016/S0140-6736(19)32233-0. PMC 6853170. PMID 31623894.
Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, Richter HE, Eder SE, Attia GR, Patrick DL, Rubin A, Shangold GA (2010). Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstetrics and Gynecology. 116 (4): 865—75. doi:10.1097/AOG.0b013e3181f20177. PMID 20859150.
Naoulou B, Tsai MC (2012). Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstetricia et Gynecologica Scandinavica. 91 (5): 529—37. doi:10.1111/j.1600-0412.2012.01361.x. PMID 22229782.
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K (2011). Henry, David A (ред.). Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd (3): CD001886. doi:10.1002/14651858.cd001886.pub4. PMC 4234031. PMID 21412876.
Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012). Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 344: e3054. doi:10.1136/bmj.e3054. PMC 3356857. PMID 22611164.
Ker K, Prieto-Merino D, Roberts I (2013). Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss (PDF). The British Journal of Surgery. 100 (10): 1271—9. doi:10.1002/bjs.9193. PMID 23839785.
Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005). Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 102 (4): 727—32. doi:10.1097/00000542-200504000-00006. PMID 15791100.
Pernik MN, Dosselman LJ, Aoun SG, Walker AD, Hall K, Peinado Reyes V, McDonagh DL, Bagley CA (2020). The effectiveness of tranexamic acid on operative and perioperative blood loss in long-segment spinal fusions: a consecutive series of 119 primary procedures. Journal of Neurosurgery. Spine. 32 (5): 768—774. doi:10.3171/2019.11.SPINE191174. PMID 31978874.
Forbes CD, Barr RD, Reid G, Thomson C, Prentice CR, McNicol GP, Douglas AS (1972). Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. British Medical Journal. 2 (5809): 311—3. doi:10.1136/bmj.2.5809.311. PMC 1788188. PMID 4553818.
van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE (2019). Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. The Cochrane Database of Systematic Reviews. 4: CD011385. doi:10.1002/14651858.CD011385.pub3. PMC 6474399. PMID 31002742.
Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ (2016). Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. The Cochrane Database of Systematic Reviews. 3: CD009733. doi:10.1002/14651858.CD009733.pub3. PMC 4838155. PMID 26978005.
Siegal DM, Garcia DA, Crowther MA (2014). How I treat target-specific oral anticoagulant-associated bleeding. Blood. 123 (8): 1152—8. doi:10.1182/blood-2013-09-529784. PMID 24385535.
Ker K, Beecher D, Roberts I (2013). Ker, Katharine (ред.). Topical application of tranexamic acid for the reduction of bleeding (PDF). The Cochrane Database of Systematic Reviews (7): CD010562. doi:10.1002/14651858.CD010562.pub2. PMID 23881695.
Logan JK, Pantle H (2016). Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department. American Journal of Health-System Pharmacy. 73 (21): 1755—1759. doi:10.2146/ajhp150829. PMID 27769971.
Williams A, Biffen A, Pilkington N, Arrick L, Williams RJ, Smith ME, Smith M, Birchall J (2017). Haematological factors in the management of adult epistaxis: systematic review. The Journal of Laryngology and Otology. 131 (12): 1093—1107. doi:10.1017/S0022215117002067. PMID 29280698.
Gottlieb M, Koyfman A, Long B (2019). Tranexamic Acid for the Treatment of Epistaxis. Academic Emergency Medicine. 26 (11): 1292—1293. doi:10.1111/acem.13760. PMID 30933392.
Moen CA, Burrell A, Dunning J (2013). Does tranexamic acid stop haemoptysis?. Interactive Cardiovascular and Thoracic Surgery. 17 (6): 991—4. doi:10.1093/icvts/ivt383. PMC 3829500. PMID 23966576.
Prutsky G, Domecq JP, Salazar CA, Accinelli R (2016). Antifibrinolytic therapy to reduce haemoptysis from any cause. The Cochrane Database of Systematic Reviews. 11: CD008711. doi:10.1002/14651858.CD008711.pub3. PMC 6464927. PMID 27806184.
Klepfish A, Berrebi A, Schattner A (2001). Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Archives of Internal Medicine. 161 (5): 767. doi:10.1001/archinte.161.5.767. PMID 11231712.
Zhou LL, Baibergenova A (2017). Melasma: systematic review of the systemic treatments. International Journal of Dermatology. 56 (9): 902—908. doi:10.1111/ijd.13578. PMID 28239840.
Taraz M, Niknam S, Ehsani AH (May 2017). Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatologic Therapy. 30 (3): e12465. doi:10.1111/dth.12465. PMID 28133910.
Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K (2019). Cochrane Eyes and Vision Group (ред.). Medical interventions for traumatic hyphema. The Cochrane Database of Systematic Reviews. 1: CD005431. doi:10.1002/14651858.CD005431.pub4. PMC 6353164. PMID 30640411.
Atsev S, Tomov N (2020). Using antifibrinolytics to tackle neuroinflammation. Neural Regeneration Research. 15 (12): 2203—2206. doi:10.4103/1673-5374.284979. PMC 7749481. PMID 32594031.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Chornenki NL, Um KJ, Mendoza PA, Samienezhad A, Swarup V, Chai-Adisaksopha C, Siegal DM (2019). Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis. Thrombosis Research. 179: 81—86. doi:10.1016/j.thromres.2019.05.003. PMID 31100632.
Law RH, Wu G, Leung EW, Hidaka K, Quek AJ, Caradoc-Davies TT, Jeevarajah D, Conroy PJ, Kirby NM, Norton RS, Tsuda Y, Whisstock JC (2017). X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors. Blood Advances. 1 (12): 766—771. doi:10.1182/bloodadvances.2016004150. PMC 5728053. PMID 29296720.
Wu G, Mazzitelli BA, Quek AJ, Veldman MJ, Conroy PJ, Caradoc-Davies TT, Ooms LM, Tuck KL, Schoenecker JG, Whisstock JC, Law RH (2019). Tranexamic acid is an active site inhibitor of urokinase plasminogen activator. Blood Advances. 3 (5): 729—733. doi:10.1182/bloodadvances.2018025429. PMC 6418500. PMID 30814058.

ncbi.nlm.nih.gov

WOMAN Trial Collaborators (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 389 (10084): 2105—2116. doi:10.1016/S0140-6736(17)30638-4. PMC 5446563. PMID 28456509.
Binz S, McCollester J, Thomas S, Miller J, Pohlman T, Waxman D, Shariff F, Tracy R, Walsh M (2015). CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media. Journal of Blood Transfusion. 2015: 874920. doi:10.1155/2015/874920. PMC 4576020. PMID 26448897.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
CRASH-3 trial collaborators (2019). Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 394 (10210): 1713—1723. doi:10.1016/S0140-6736(19)32233-0. PMC 6853170. PMID 31623894.
Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K (2011). Henry, David A (ред.). Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd (3): CD001886. doi:10.1002/14651858.cd001886.pub4. PMC 4234031. PMID 21412876.
Ker K, Edwards P, Perel P, Shakur H, Roberts I (2012). Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 344: e3054. doi:10.1136/bmj.e3054. PMC 3356857. PMID 22611164.
Forbes CD, Barr RD, Reid G, Thomson C, Prentice CR, McNicol GP, Douglas AS (1972). Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. British Medical Journal. 2 (5809): 311—3. doi:10.1136/bmj.2.5809.311. PMC 1788188. PMID 4553818.
van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE (2019). Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. The Cochrane Database of Systematic Reviews. 4: CD011385. doi:10.1002/14651858.CD011385.pub3. PMC 6474399. PMID 31002742.
Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ (2016). Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. The Cochrane Database of Systematic Reviews. 3: CD009733. doi:10.1002/14651858.CD009733.pub3. PMC 4838155. PMID 26978005.
Moen CA, Burrell A, Dunning J (2013). Does tranexamic acid stop haemoptysis?. Interactive Cardiovascular and Thoracic Surgery. 17 (6): 991—4. doi:10.1093/icvts/ivt383. PMC 3829500. PMID 23966576.
Prutsky G, Domecq JP, Salazar CA, Accinelli R (2016). Antifibrinolytic therapy to reduce haemoptysis from any cause. The Cochrane Database of Systematic Reviews. 11: CD008711. doi:10.1002/14651858.CD008711.pub3. PMC 6464927. PMID 27806184.
Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K (2019). Cochrane Eyes and Vision Group (ред.). Medical interventions for traumatic hyphema. The Cochrane Database of Systematic Reviews. 1: CD005431. doi:10.1002/14651858.CD005431.pub4. PMC 6353164. PMID 30640411.
Atsev S, Tomov N (2020). Using antifibrinolytics to tackle neuroinflammation. Neural Regeneration Research. 15 (12): 2203—2206. doi:10.4103/1673-5374.284979. PMC 7749481. PMID 32594031.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Law RH, Wu G, Leung EW, Hidaka K, Quek AJ, Caradoc-Davies TT, Jeevarajah D, Conroy PJ, Kirby NM, Norton RS, Tsuda Y, Whisstock JC (2017). X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors. Blood Advances. 1 (12): 766—771. doi:10.1182/bloodadvances.2016004150. PMC 5728053. PMID 29296720.
Wu G, Mazzitelli BA, Quek AJ, Veldman MJ, Conroy PJ, Caradoc-Davies TT, Ooms LM, Tuck KL, Schoenecker JG, Whisstock JC, Law RH (2019). Tranexamic acid is an active site inhibitor of urokinase plasminogen activator. Blood Advances. 3 (5): 729—733. doi:10.1182/bloodadvances.2018025429. PMC 6418500. PMID 30814058.

patient.co.uk

Allen, Helen (13 червня 2012). Tranexamic acid for bleeding. Patient UK. Архів оригіналу за 25 травня 2014.

rcog.org.uk

Postpartum Haemorrhage, Prevention and Management (Green-top Guideline No. 52). Royal College of Obstetricians & Gynaecologists-US. Процитовано 16 січня 2018.

web.archive.org

Cyklokapron Tablets - Summary of Product Characteristics (SPC) - (eMC). www.medicines.org.uk. September 2016. Архів оригіналу за 20 грудня 2016. Процитовано 14 грудня 2016.
Tranexamic acid Use During Pregnancy | Drugs.com. www.drugs.com. Архів оригіналу за 21 грудня 2016. Процитовано 14 грудня 2016.
Tranexamic Acid Injection - FDA prescribing information, side effects and uses. www.drugs.com. Архів оригіналу за 21 грудня 2016. Процитовано 14 грудня 2016.
Cherkas D (2011). Traumatic hemorrhagic shock: advances in fluid management. Emergency Medicine Practice. 13 (11): 1—19, quiz 19–20. PMID 22164397. Архів оригіналу за 18 січня 2012.
Drug will save lives of accident victims, says study. BBC News. 2010. Архів оригіналу за 24 червня 2010. Процитовано 3 червня 2016.
Lysteda (tranexamic acid) Package Insert (PDF). accessdata.FDA.gov. Архів оригіналу (PDF) за 4 березня 2016. Процитовано 2 листопада 2015.
Cyklokapron (tranexamic acid) Product Information (PDF). Архів оригіналу (PDF) за 29 лютого 2016. Процитовано 3 листопада 2015. [Архівовано 2016-02-29 у Wayback Machine.]
Tranexamic Acid use while Breastfeeding. www.drugs.com. 2014. Архів оригіналу за 18 вересня 2016. Процитовано 27 травня 2016.
19th WHO Model List of Essential Medicines (PDF). WHO. 2015. Архів оригіналу (PDF) за 13 травня 2015. Процитовано 10 травня 2015.
Chapman, Chris (27 січня 2011). Tranexamic Acid to be available OtC. Community pharmacy news, analysis and CPD. Архів оригіналу за 9 жовтня 2011. [Архівовано 2011-10-09 у Wayback Machine.]
Chapman, Chris (10 лютого 2011). In defence of multiple pharmacies. Community pharmacy news, analysis and CPD. Архів оригіналу за 28 березня 2012. [Архівовано 2012-03-28 у Wayback Machine.]
Allen, Helen (13 червня 2012). Tranexamic acid for bleeding. Patient UK. Архів оригіналу за 25 травня 2014.

who.int

https://www.who.int/reproductivehealth/tranexamic-acid-pph-treatment/en/
19th WHO Model List of Essential Medicines (PDF). WHO. 2015. Архів оригіналу (PDF) за 13 травня 2015. Процитовано 10 травня 2015.